To further investigate whether Cori treatment has an improvement effect on glucose intolerance and insulin resistance during the progressive development of NAFLD, we performed glucose tolerance test (GTT) and insulin tolerance test (ITT) assays. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.